Clinical trial
The NORwegian Atrial Fibrillation Self-SCREENing
NCT05914883 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The NORwegian Atrial Fibrillation Self-SCREENing
- Lead sponsor
- Oslo University Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- September 1, 2023
- Completion date
- December 31, 2029
- Enrollment
- 50,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.